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Abstract
Background: In response to the escalating burden of chronic illness in Australia, recent health
policies have emphasised the promotion of patient self-management and better preventive care. A
notable omission from these policies is the acknowledgment that patients with chronic illness tend
to have co-morbid conditions. Our objectives were: to identify the common challenges co-
morbidity poses to patients and carers in their experiences of self-management; to detail the views
and perceptions of health professionals about these challenges; and to discuss policy options to
improve health care for people with co-morbid chronic illness. The method included semi-
structured interviews and focus groups with 129 purposively sampled participants. Participants
were people with Type 2 diabetes, chronic obstructive pulmonary disease and/or chronic heart
failure as well as carers and health care professionals. Content analysis of the interview data was
conducted using NVivo7 software.
Results: Patients and their carers found co-morbidity influenced their capacity to manage chronic
illness in three ways. First, co-morbidity created barriers to patients acting on risk factors; second,
it complicated the process of recognising the early symptoms of deterioration of each condition,
and third, it complicated their capacity to manage medication.
Conclusion: Findings highlight challenges that patients with multiple chronic conditions face in
relation to preventive care and self-management. Future clinical policy initiatives need to move
away from single illness orientation toward strategies that meet the needs of people with co-
morbid conditions and strengthen their capacity to self-manage. These patients will benefit directly
from specialised education and services that cater to the needs of people with clusters of co-
morbidities.
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In response to the escalating burden of chronic illness in
Australia, the Council of Australian Governments insti-
gated the Better Health for All Initiative [1] in line with the
2005 National Chronic Disease Strategy [2]. Central to
these changes is the promotion of patient self-manage-
ment and better preventive care through increased patient
support to act on risk factors [3,4]. State and territory gov-
ernments have developed policies consistent with this. At
federal, state and territory government levels, policy initi-
atives are primarily single-illness oriented and this is
reflected in many aspects of organisation planning and
delivery of health services [5]. A notable omission from
these policies is the acknowledgment that patients with
chronic illness tend to have co-morbid conditions, the
prevalence of which increases with age [6-8]. The relation-
ship between chronic heart failure (CHF) and co-morbid
depression is well-established [9,10]. However, a prelimi-
nary review of the literature indicates few studies address
the impact of other co-morbid conditions on chronic dis-
ease management.
The Serious and Continuing Illnesses Policy and Practice
Study (SCIPPS) is a five-year National Health and Medical
Research Council-funded research program that focuses
on better policy for improving patient experience in man-
aging chronic illness. Three conditions--Type 2 diabetes
mellitus (DM), chronic obstructive pulmonary disease
(COPD), and chronic heart failure CHF--were studied as
they have a high prevalence in Australia, and for each one
clinical prevention is known to be effective. A qualitative
study that forms the basis for this paper was undertaken
involving 52 patients, 14 carers and 63 health care profes-
sionals (HCP). Eighty-seven per cent of patients indicated
they had more than one chronic illness. Without being
prompted by the interviewer, 55 of the 66 patients and
carers raised co-morbidity as a complicating factor in their
experience of chronic illness (and in response to prompt-
ing, a further two patients discussed co-morbidity as a
complicating factor). Common patterns emerged from
interrogation of the co-morbidity data and these patterns
are reported in this paper, which has the following aims:
• To describe the common challenges co-morbidity
poses to patients and family carers in their experiences
of managing chronic illness
• To report HCP perspectives on these challenges
• To discuss the policy challenges these findings pose.
Methods
The study used a generic qualitative approach [11] to
explore the experiences and perspectives of patients with
DM, COPD and/or CHF, family carers and health care
professionals. Data collection and analysis were carried
out by a group of seven research workers with multidisci-
plinary backgrounds in health and social sciences, all of
whom trained as a group in workshops and followed a
data collection manual to ensure consistency in data col-
lection and analysis.
The definition of co-morbidity used in this study was "the
coexistence of chronic conditions within the context of an
index condition" [12]. The target population of this study
were people affected by DM, COPD and/or CHF; there-
fore, in this paper, 'index condition' refers to those condi-
tions. When patients had two or three index conditions,
the conditions were counted as co-morbid and data were
analysed in terms of problems that occurred as a result of
the patient having two or more conditions.
Sample
We used purposive sampling in order to obtain a range of
patients and carers with varied demographics including
age, ethnicity and severity of the illness. Patients and car-
ers were recruited through referrals from general practices,
local hospitals, community health services, specialist clin-
ics, health care consumer organisations, as well as Aborig-
inal health services located in the Australian Capital
Territory (ACT) and western suburbs of Sydney in Aus-
tralia. Eligible participants included patients aged
between 45 and 85 with one or more of the three condi-
tions of interest (DM, COPD and CHF), who at the time
of interview were living in either the ACT or western Syd-
ney and did not have diagnosed cognitive impairment
and family carers.
Health care professionals who had specific experience in
the management of the index conditions were recruited
through Divisions of General Practice and Area Health
Services to include hospital specialists, general practition-
ers, nurses and allied health professionals. HCPs were
included to provide contextual insight on the health sys-
tem.
Procedure
Study approval was obtained from the relevant institu-
tional human research ethics committees and all partici-
pants provided informed consent prior to their
participation. Data collection occurred between March
2007 and January 2008. Semi-structured in-depth inter-
views were conducted with patients and with carers; each
interview running between 45 and 90 minutes. Patients
and carers then completed a 10-minute demographic sur-
vey, which contained information about patient health
conditions and health care encounters. One question
included in the survey was, 'Apart from the CHF, COPD
and/or DM do you have any other health conditions? If
yes, please list all conditions (chronic and acute) andPage 2 of 8
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ified survey questions as required and provided practical
assistance in completing the surveys.
All health care professionals participated in one-hour
focus groups, with the exception of two HCPs who were
interviewed separately. HCPs completed a two-minute
survey about the extent and duration of their work in
chronic illness. Although many of the HCPs who recruited
patients and carers to the study also participated in the
focus groups, the individual patient/carer data were not
designed to be linked to HCP data. The research team
judged sufficient data had been gathered when interviews
and focus groups were no longer providing new insights
or ideas deemed central to the experience of patients and
carers, indicating data saturation [13].
Interview questions
The patient and carer interviews began with a question
asking the participant what it was like to live (or care for
someone) with chronic illness. Other questions covered
(but were not limited to) the most challenging aspects of
their chronic illness, experiences with health services and
health care providers and support they wanted and/or
experienced in managing their chronic illness.
In their responses, many patients and their family carers
raised challenges they faced in the management of
chronic illness that was either caused, or made worse, by
co-morbidity. Based on these findings co-morbidity was
further explored with HCPs. Questions to HCPs concern-
ing co-morbidity included: 'what are the main problems
that people with multiple conditions face and what are
the main reasons for the problems?'
Analysis
All interviews and focus groups were electronically
recorded and transcribed verbatim. The data were ana-
lysed using qualitative content analysis [13], assisted by a
computerised qualitative data analysis program, QSR
NVivo7 [14]. A coding scheme was created during the data
collection phase and used to facilitate consistent data
analysis by seven researchers across the two research sites.
The coding scheme was refined by the collective research-
ers periodically throughout the data analysis and research-
ers regularly engaged in checking each other's
interpretation accuracy of the data against the coding
scheme. Strategies to ensure rigour were developed and
adopted based on the work of Lincoln and Guba (1985)
[15]. This included: extensive research worker training
and practice in interview skills and data analysis; a pilot to
assure adequacy of data collection and recruitment; devel-
opment and meticulous implementation of data collec-
tion and analysis protocols; maintenance of inter-coder
reliability according to established analysis protocol; and
examination of qualitative data against relevant partici-
pant survey data. Descriptive analysis (frequencies,
means, modes and medians) of the survey data was
undertaken using SPSS version 15 [16]. In analysis of the
co-morbidity data the first and second authors identified
problems that participants experienced as a result of hav-
ing two or more chronic health conditions.
Results
Sample characteristics
A total of 52 patients (male n = 28) and 14 carers (male n
= 1) were recruited. Of these, 27 patients had DM, 17
patients had COPD and 20 patients had CHF. The total
number combines to more than 52 because 10 patients
had two of these conditions and one patient had all three
conditions. This study succeeded in recruiting patients
and carers from diverse cultural and ethnic backgrounds
(n = 23), including seven Indigenous patients. Most
patients and carers were older than 65 years (n = 42),
experienced economic hardship (n = 42), had a decade-
long history of chronic illness (mean = 16.5 years) and
had monthly or more frequent contact with general prac-
titioners (GPs).
Forty-five patients had co-morbid chronic illness. The
common co-morbidities included the index conditions of
arthritis, osteoporosis, asthma, and back pain. Depression
and pneumonia were two conditions commonly dis-
cussed by patients; most of whom at the time of the inter-
view did not have the condition but were mindful that
they were prone to recurrences.
Of the 63 health care provider (HCP) participants, most
were female (n = 44) and working full time (n = 55). The
majority of HCP participants were registered nurses (n =
23) and physicians (n = 21, 15 GPs and six specialists).
Other participating HCPs included physiotherapists, care
coordinators, managers, occupational therapists, podia-
trists, psychologists and social workers. The length of HCP
work experience varied from less than one year to 33 years
(median = 8 years). There were 12 HCP participants who
listed their role in chronic disease management as "non-
clinical work," meaning they were not involved in direct
patient care, yet played a major role in the service provi-
sion for this population.
Common challenges posed by co-morbidity
Co-morbidity increased the amount of time participants
spent managing their health and increased patients'
dependency on others. Patients with co-morbid condi-
tions encountered problems with the coordination
between services and with polypharmacy. Patients priori-
tised the management of one condition over another;
consequently, some health issues could be neglected or
compromised. The three most common challenges toPage 3 of 8
(page number not for citation purposes)
Australia and New Zealand Health Policy 2009, 6:22 http://www.anzhealthpolicy.com/content/6/1/22patients and carers in managing chronic illness (either
caused or made worse by co-morbidity), relate to acting
on risk factors, recognising signs and symptoms of illness
and managing medications. Table 1 indicates key issues
that patients and carers discussed in connection with co-
morbidity.
Capacity to act on risk factors
Risk factors are variables known to increase a person's risk
of illness or deterioration in health; the term 'risk factor'
was used by HCPs but not by patients and carers. Com-
mon risk factors that patients and carers discussed
included physical inactivity, poor diet, stress, smoking
and excessive alcohol consumption. While patients and
their carers indicated an awareness that changing their
lifestyle would prevent further deterioration, co-morbid-
ity frequently prevented them from acting on risk factors
effectively--raising feelings of guilt, frustration, depression
and anxiety.
Many patients found it difficult to maintain a healthy diet
(a topic raised especially by patients who had both DM
and CHF). Clinical depression was a common co-morbid
condition that reduced patient motivation to follow a
healthy diet or exercise. For some patients co-morbid con-
ditions such as arthritis delayed completion of rehabilita-
tion programs or caused them to withdraw from the
program:
There were people older than me [in the cardiac reha-
bilitation program] and I couldn't keep up with them
because of my ankle. That's how I went to the doctor
and I showed them and I got arthritis. That was why I
couldn't walk properly. ...I got an exercise bike. I look
at it a lot, that bloody bike. Bit slack.
Man in his sixties with DM and CHF
Similarly, HCPs reported that co-morbid conditions, in
particular arthritis and depression, could limit usefulness
of rehabilitation programs for patients' index chronic con-
ditions. Premature withdrawal of patients from rehabilita-
tion programs due to co-morbid conditions was costly, as
was extended participation in programs, which was per-
Table 1: Patient and carer perspectives on challenges associated with co-morbidity
Challenges associated with co-morbidity Co-morbidity (n = 57)
Acting on risk factors 13
Recognising change in illness condition 31
Being on guard/alert to changes 11
Illness management mechanism (inc. medication) 35
Uncertainty 13
Learning 18
Planning (inc. medication & diet) 12
Adverse effects of medication 05
Remaining positive 13
Managing abnormal blood sugar levels 13
Complications in illness (caused by index condition) 13
Living with anxiety and fear 26
Obtaining quality care 21
Balancing life and illness 19
Physical or social activities 17Page 4 of 8
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already under considerable strain:
So we can either treat the ones that we do very well and
neglect all the ones who are trying to get in who also
need it, or we ditch them before they've done their
best work to try and get more in. You can't win either
way. So that's again a lack of resources and availability.
HCP in the ACT
This perception of resource restraints explained why HCPs
deterred people with multiple conditions from staying in
rehabilitation programs.
Capacity to recognise the signs and symptoms of illness
Co-morbidity made it difficult for patients to recognise
signs and symptoms of the index condition, especially
early warnings of an exacerbation. This concern was raised
more frequently by patients with CHF than by patients
with DM or COPD. A woman in her seventies with DM,
asthma and CHF said: "It is very hard for me to say
whether it is my heart that I am short of breath with or
asthma." Learning about the features of both their index
condition and co-morbid conditions took much longer
than simply learning about the features of a single condi-
tion. A carer explained that with her mother's recent diag-
nosis of DM they remained unsure whether her mother's
mini-strokes were symptoms of DM or indicating a sepa-
rate condition:
We don't know actually [what caused the mini-
strokes]. Well, she did have a couple of episodes, I
don't know if they would have been the mini-strokes,
if they would have been diabetes or what it would
have been. But of course ...she was only diagnosed
recently [with DM].
Daughter carer in her fifties of a woman with DM
Patients indicated they learnt how to recognise signs and
symptoms of exacerbation by applying information
gained through various sources (written sources, conver-
sations with health professionals, friends and family) to
their personal experience in a process of trial and error. A
wife carer of a man with DM and Alzheimer's disease
learnt over time to differentiate between the signs and
symptoms associated with each illness:
Sometimes he'd get a little bit tired and in a second
he'd fell and hit his head. He would slur his words and
things like that but I knew he had the symptoms of no
sugar. ...Over time, you just realise that this is what's
going on.
Wife carer in her seventies of a man with DM
Patients said they wanted more information that
addresses the links between co-morbid conditions to facil-
itate their self-management.
Health care professionals reiterated the difficulty for
patients in recognising signs and symptoms of co-morbid
conditions, noting that this is a particular problem for
patients with limited health knowledge. HCPs further
explained that even when patients did correctly identify
new symptoms they did not always know how to respond
and so ended up in hospital or suffered unnecessarily at
home.
Capacity to manage medications
Four out of five patients had co-morbid conditions. A
total of 38 patients received treatment with medication
for at least one of their conditions and 20 patients were
prescribed seven or more medications, each with their
own daily regimen. Patients found managing medication
for their numerous conditions to be complicated, time-
consuming, inconvenient and confusing. They raised con-
cerns of insufficient knowledge about drug interactions
and side-effects, and not being able to manage their med-
ications. Others did not follow medication recommenda-
tions because they did not like taking pills. For example, a
woman with DM and CHF did not take her prescribed
medication for DM management because she did not
want to increase the number of pills she was already tak-
ing (for management of CHF): "I'm on so many heart tab-
lets and things like that, I didn't want to take any [more]
medication, so I went for diet, and diet control." This is
also an example of the patient prioritising treatment of
one condition over another.
Many patients demonstrated limited knowledge and
understanding of their medications and were unable to
differentiate between them. A carer in her fifties of a
woman with DM said: "I have to do the medicines these
days. ...I kept noticing she didn't know what to call the
tablets and stuff and now she's got over 20 tablets [daily]."
Similarly, a farmer with DM and COPD said: "Well I'm
not too sure what they're for but I know they're either for
diabetes or for me heart, or cholesterol, or high blood
pressure." While blister packs preloaded with medication
were often perceived as helpful in managing medications,
some people with the packs found they no longer knew
what medication they were taking and could not distin-
guish between medications. Cognitive impairment or
dementia further impaired their ability to manage, and in
many cases their carers had taken over that task.
Patients discussed the complex process of finding suitable
medications to manage their conditions, noting that oftenPage 5 of 8
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fessionals, which in turn was dependent on patient aware-
ness of signs and symptoms associated with their
numerous conditions. HCPs raised other critical elements
influencing medication compliance such as patient hon-
esty or recall/forgetfulness about which medications they
were actually taking. HCPs indicated financial constraints
and the cost of filling scripts often caused patients with co-
morbid conditions to skip medications they thought were
less important than others. One HCP said:
They tend to pick and choose which... scripts they get
filled, because they've got so many things going on at
once... And the whole issue of medication manage-
ment arises and it escalates their co-morbidity.
HCP in the ACT
Several health care professionals indicated that medica-
tion management and non-compliance were particular
problems with patients with mental illness. They sug-
gested that better access to mental health care providers
could improve medication management for these
patients. HCPs also suggested that lack of awareness by
HCPs and patients concerning risks involved in using
multiple medication brand names could lead to patients
unknowingly taking doses higher than prescribed, result-
ing in ill health, and that this could go unnoticed.
Patients, carers and HCPs suggested that the capacity to
manage medication could be improved through increased
education, patient engagement and good communication
between patients and their HCPs.
Discussion
Patients and their carers found co-morbidity limited their
capacity to manage chronic illness by diminishing patient
ability to reduce risks, recognise symptoms of exacerba-
tion and to manage medication. We discuss these three
issues in turn and suggest specific policy and practice
implications of the findings. First, co-morbidity dimin-
ished patients' ability to act on risk factors, which has
been noted in other literature [9,17-19]. Future manage-
ment strategies and guidelines should be informed by dia-
logue between patients and professionals as well as
lessons learnt in studies addressing specific co-morbidi-
ties clusters [19-22]. One solution to the challenge of
maintaining an exercise regimen would be for cardiac and
pulmonary rehabilitation programs to undergo re-design,
catering to the needs of COPD and CHF participants with
common co-morbid conditions such as arthritis. Policy
interventions that offer incentives to rehabilitation pro-
grams could effectively initiate the required changes to
increase the programs' capacity to meet more common
combinations of co-morbid conditions. The success of
this solution will depend on the increased understanding
of co-morbidity among HCPs and their increased commu-
nication between specialities [22]. Existing initiatives such
as the Enhanced Primary Care Multidisciplinary Case
Conferencing and Care Plans, or The Australian Govern-
ment's Health Connect program facilitate communication
between specialities and increasing their uptake will ben-
efit patients with co-morbid illness [23-26].
Second, co-morbidity made it difficult for patients to
identify signs and symptoms of an exacerbation of an
index condition. Kerr, Heisler, and Krein et al. (2007)
found complications occurred when patients prioritised
the self-management of one condition over another [18].
However, our findings suggest it is the complexity of the
knowledge required and the confusing nature of the
symptoms that prevent patients from recognising physical
and psychological changes. The ability to recognise signs
and symptoms of each illness is an important aspect of
self-care and care planning [27,28] and patients may ben-
efit from policy that promotes patient health knowledge
through self-management planning. Much written patient
information provided in primary care settings is disease-
specific. Many non-government organisations are orien-
tated towards single diseases or organs (e.g. Diabetes Aus-
tralia or the National Heart Foundation). Recent policies
such as the 2005 National Chronic Disease Strategy focus
on common single conditions rather than co-morbid
issues. All these observations reflect the dominant disease
silo orientation of current Australian policy and practice
[26,27].
The third limitation was that co-morbidity interfered with
patient capacity to manage their medications and adhere
to medication regimens. This was made worse by polyp-
harmacy, poor medication literacy or confusion about
regimens, and financial pressure [29-32]. Patients may
benefit from medication education and services that
address these complications [31,33]. In Australia this has
been addressed through a pharmacist in-home patient
medication review as part of a GP care plan called the
Domiciliary Medication Management Review (DMMR).
This review has had slow uptake across Australia because
of pharmacist workforce shortages, pharmacists needing
to be accredited before they can access the item, insuffi-
cient financial incentives, insufficient collaboration
between pharmacists and GPs and insufficient promotion
of the item [34]. These factors need to be addressed to
support the needs of patients who have co-morbid condi-
tions [34,35]. None of the participants in our study men-
tioned the DMMR, which might reflect the initiative's
shortfalls.
These three difficulties in self-management, which stem
from co-morbidity, have been recognised in other studies
as well. The Kaiser Model of Stratified Care according toPage 6 of 8
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concerning self-management and patient decision-mak-
ing support [37], are two widely used models of care that
support the promotion of patient education and collabo-
ration between patients and HCPs for effective self-man-
agement. There is room within these models to address
the needs of people with multiple conditions. Research is
now needed to address specific combinations of illnesses
that are known to be co-morbid and highly prevalent. This
kind of research may suggest modifications to the existing
chronic care models and will inform policy initiatives at
national and state levels that aim to improve patients'
capacities to act on risk factors, knowledge of signs and
symptoms, and capacity to manage medication.
Limitations
We did not aim for generalisability; rather, we aimed for a
representative sample of patients with the three index
conditions, saturation of issues raised in responses from
our participants, and coherent interpretations of our data.
While the research was conducted across two local sites
the findings do not indicate they are site-specific.
Conclusion
The majority of patients with DM, COPD or CHF have co-
morbid conditions. At a clinical level, co-morbidity is a
complication that challenges the management of chronic
illness by patients and their carers. Given its frequency,
future clinical policy initiatives need to move away from
single illness orientation towards strategies that embrace
the needs of people with co-morbid conditions to
strengthen patient capacity to self-manage.
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